Neuralzome, Eyestem, and Graas.ai secure financial backing
Singapore-based AI-native data and automation company, Graas.ai, has secured $9 million in a pre-Series B round, led by Tin Men Capital. The funding will be used to expand its proprietary platform, Agent Foundry, in India.
Graas.ai's Agent Foundry is a platform designed to solve key ecommerce operational challenges, such as reducing customer acquisition costs, optimizing pricing, protecting profit margins, and managing inventory effectively. The platform builds autonomous AI agents that actively run operational plays, making commerce operations more autonomous and efficient.
The expansion plans for Agent Foundry include accelerating its rollout and adoption, helping over 2,000 supported brands automate fragmented dashboards, disconnected tools, and manual workflows through AI-native automation. Graas.ai also plans to introduce a multi-agent framework, enabling bespoke agent creation tailored to specific commerce challenges.
The platform will deploy agents like Hoppr (analytics agent), Cartlyst (B2B order processing assistant), and Chattr (AI customer support assistant) to drive automation and efficiency in ecommerce operations.
The funding round also included investors such as Incred Wealth, Orzon, Integra Partners, and Yuj Ventures, signifying strong investor confidence in the company’s vision and technology.
Meanwhile, in the biotechnology sector, Eyestem Research Pvt Ltd raised $10 million in a funding round for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE. The raised capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA).
Eyecyte-RPE, derived from human induced pluripotent stem cells (hiPSCs), is a retinal cell therapy designed to replace damaged or lost retinal pigment epithelial (RPE) cells and potentially enable tissue regeneration in the diseased retina.
In another development, Neuralzome Cybernetic raised $2.4 million (approximately Rs 21 crore) in a pre-seed funding round, led by 8X Ventures. Neuralzome follows a robot-as-a-service (RaaS) model to serve labor-intensive industries such as orchard management and commercial landscaping.
Founded in 2023, Neuralzome builds no-code AI agents for quick deployment of robots without in-house robotics expertise. The funds raised will be used for advancing R&D in multi-agent autonomy and vision-based navigation, increasing manufacturing, and expanding to North America and Europe.
These developments highlight the growing interest and investment in AI and biotechnology sectors, with companies like Graas.ai, Eyestem, and Neuralzome leading the way in their respective fields.
